Aptevo Therapeutics Cash Flow Statement (2015-2023) | APVO

Cash Flow Statement Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023
Operating Activities
Net Income -17.72M-12.68M-17.90M-12.89M-12.84M3.96M2.31M2.59M3.97M56.14M0.16M0.05M0.01M0.04M-11.44M-12.90M5.16M1.86M-6.81M0.16M0.12M0.41M0.13M0.08M0.33M0.18M0.15M0.17M0.52M
Share-based Compensation 0.28M0.28M2.69M0.40M1.33M1.74M1.68M1.10M1.04M1.05M0.72M0.45M0.48M0.59M0.40M0.33M0.27M0.41M0.30M0.34M0.20M0.57M0.57M0.32M0.18M0.60M0.48M0.36M0.36M0.92M0.47M0.46M
Deferred Taxes -0.67M-0.01M-0.01M-0.48M-15.31M-7.49M
Gains from Sales and Divestitures 1.32M1.43M1.56M1.00M1.05M1.06M1.06M0.12M0.13M0.13M0.13M0.01M0.00M0.01M0.01M0.02M0.02M0.05M0.05M0.10M
Gains from Investment Securities -0.12M0.15M-0.03M0.05M-0.28M-0.18M2.51M3.02M2.82M0.19M0.03M3.36M3.33M0.10M0.10M0.33M0.39M0.34M0.31M0.33M292.000.37M0.35M0.33M0.03M0.40M0.40M0.47M
Asset Writedowns and Impairment 55.70M15.31M
Non-cash Items 0.46M0.16M1.12M1.17M5.16M2.60M1.47M1.59M1.60M2.06M2.20M1.90M0.06M0.19M0.18M1.40M3.40M4.60M4.40M3.80M43.21M2.60M2.30M2.10M0.19M1.50M0.26M1.00M
Cash from Operations -9.36M-7.68M-14.11M-15.95M-0.13M-6.67M-12.03M-12.51M-1.62M-15.42M-16.98M-32.98M-44.13M-13.84M-15.89M-7.55M-5.10M-11.18M-4.63M-7.39M-6.12M-7.50M-5.05M-5.24M-3.88M-5.12M-3.07M-6.90M-5.94M4.57M-4.80M-6.24M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 0.81M0.84M0.88M1.20M0.45M0.84M0.88M1.27M0.14M0.59M1.19M1.78M0.58M0.57M0.55M0.53M0.46M0.31M0.30M0.34M0.29M0.30M0.29M0.26M0.24M0.28M0.22M0.16M0.18M0.15M0.12M
Change in Working Capital
Change in Receivables 1.00M-5.87M-3.00M5.06M-5.55M1.32M-0.12M1.35M-1.01M1.61M0.96M4.00M4.06M0.58M1.58M0.54M-0.90M
Change in Inventory 1.18M-1.40M1.75M-1.94M-8.56M-4.93M1.34M0.12M-0.69M-0.21M0.26M1.94M2.94M2.56M2.62M0.52M-1.34M
Change in Accured Expenses 1.08M-2.63M1.35M-1.54M-0.96M3.63M-4.92M-0.22M3.20M2.14M-3.37M-1.84M-0.43M0.37M-1.61M1.08M-2.54M-3.25M0.01M0.41M2.12M-2.11M-0.04M0.46M-0.22M-0.80M-1.45M0.86M0.99M-0.91M1.11M-0.08M
Change in Taxes 0.53M
Other Working Capital Changes 1.24M-4.83M3.09M-6.52M0.00M-0.03M0.81M-0.51M-4.01M-0.10M1.36M1.57M-0.12M-2.15M-2.42M2.48M1.33M-1.83M0.95M0.66M-0.71M-0.65M1.40M-0.47M-0.30M-0.95M0.62M0.28M0.84M-1.48M0.34M
Investing Activities
Capital Expenditures 0.44M0.52M1.07M0.91M-0.05M0.58M0.79M0.18M0.14M0.30M0.47M0.57M0.93M0.15M0.19M0.39M0.01M0.12M0.00M
Divestments -0.71M0.05M0.07M0.07M28.12M
Change in Acquisitions & Divestments 8.10M21.09M24.03M17.51M25.93M52.84M81.15M
Cash from Investing Activities -0.44M-0.52M-1.07M-0.91M-49.76M4.34M-2.83M20.77M65.36M-53.84M23.51M35.81M63.76M-0.15M4.25M28.12M-0.09M-0.19M-0.39M-0.01M-0.12M-0.00M
Financing Activities
Other financing activities 2.36M0.81M0.00M-0.66M-10.15M0.60M
Cash from Financing Activities 9.22M9.36M13.62M19.28M55.29M1.11M19.20M-0.01M-0.18M0.53M-0.56M-0.24M-0.83M20.37M-0.11M0.02M-0.14M-22.10M24.73M21.25M23.94M8.32M-3.02M-3.08M-4.94M-3.18M-0.50M6.00M-1.87M0.48M4.34M
Additional items
Change in Cash -0.57M1.16M-1.56M2.42M5.40M-1.22M4.34M8.26M63.56M-68.73M5.98M2.58M18.80M6.38M-16.00M-3.27M-5.24M-5.16M-4.63M17.34M15.04M16.25M2.87M-8.28M-7.07M-10.05M-6.27M-7.40M0.06M2.69M-4.32M-1.90M
Free Cash Flow -9.79M-8.20M-15.18M-16.86M-0.09M-7.24M-12.82M-12.69M-1.75M-15.72M-17.45M-33.55M-45.06M-14.00M-15.89M-7.55M-5.10M-11.18M-4.63M-7.39M-6.12M-7.70M-5.44M-5.25M-4.00M-5.12M-3.07M-6.90M-5.94M4.57M-4.80M-6.24M
Net Cash Flow -0.57M1.16M-1.56M2.42M5.40M-1.22M4.34M8.26M63.56M-68.73M5.98M2.58M18.80M6.38M-16.00M-3.27M-5.24M-5.16M-4.63M17.34M15.04M16.25M2.87M-8.28M-7.07M-10.05M-6.25M-7.40M0.06M2.69M-4.32M-1.90M